Every corporate transaction in India must satisfy three independent regimes simultaneously: commercial, regulatory, and tax. Each applies its own methodology. Each references its own benchmark. None of them are calibrated to each other.
This divergence is structural – the commercial valuation reflects negotiated value between informed parties, the regulatory valuation enforces a statutory floor or ceiling depending on the instrument and the applicable regime, while the tax valuation applies its own deeming fiction, independent of what was actually paid, what was commercially justified, and what every other regulator approved.
The result is that a transaction can be commercially sound, regulatorily compliant, and tax-inefficient all at the same time. S. 56(2)(x) taxes the investor on value not received. S. 50CA deems consideration the seller never collected. Regulatory approvals, automatic or specific, do not help; a valuation report does not help; arms’ length valuation does not help.
The deck below maps this divergence across different transaction scenarios, reflecting the current legal position post-Budget 2026.